Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ)
and risk of critical outcome among COVID-19 patients

dc.contributor.author	Camblor, D. G.
dc.contributor.author	Miranda, D.
dc.contributor.author	Muñiz Albaiceta, Guillermo
dc.contributor.author	Amado Rodríguez, Laura
dc.contributor.author	Cuesta Llavona, Elías
dc.contributor.author	Vázquez Coto, D.
dc.contributor.author	Gómez de Oña, J.
dc.contributor.author	García Lago, C.
dc.contributor.author	Muñoz Gómez, J.
dc.contributor.author	Coto García, Eliecer
dc.date.accessioned	2023-03-15T10:33:58Z
dc.date.available	2023-03-15T10:33:58Z
dc.date.issued	2022
dc.identifier.citation	Human Immunology, 83, p. 613-617 (2022); doi:10.1016/j.humimm.2022.06.002
dc.identifier.issn	0198-8859
dc.identifier.uri	http://hdl.handle.net/10651/66999
dc.format.extent	p. 613-617
dc.language.iso	eng
dc.relation.ispartof	Human immunology
dc.rights	© 2022 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc.
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85133399297&doi=10.1016%2fj.humimm.2022.06.002&partnerID=40&md5=bb76ad7080e4ab51d262b36432997090
dc.title	Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients
dc.type	journal article
dc.identifier.doi	10.1016/j.humimm.2022.06.002
dc.relation.publisherversion	http://dx.doi.org/10.1016/j.humimm.2022.06.002

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.